D-1216-2015 Class I Terminated

Recalled by Hospira Inc. — Lake Forest, IL

FDA drug recall D-1216-2015 was initiated by Hospira Inc. on Apr 23, 2015 and is designated Class I. Reason for recall: Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles. The recall status is terminated (terminated Jan 26, 2016). Affected quantity: 150,950 Vials.

Recall Details

Product Type
Drugs
Report Date
Jul 15, 2015
Initiation Date
Apr 23, 2015
Termination Date
Jan 26, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
150,950 Vials

Product Description

Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL Single Use Vials, Rx only. HOSPIRA, INC., LAKE FOREST, IL 60045 USA. NDC: 0409-1162-02.

Reason for Recall

Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.

Distribution Pattern

U.S. Nationwide including Guam.

Code Information

Lot #: 38-515-DK, Expiry: 1 FEB 2016.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1216-2015
openFDA file date
Oct 27, 2026
Loaded by RegDataLab
Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.